Newsletter from CLS, September 2023
CLS is committed to developing better therapies for use in cancer care and neurosurgery. In this edition of our newsletter, you can read more about CLS’s commercial and medical milestone that was achieved at AVANT Concierge Urology in the US, and exhibitions where our TRANBERG® system and the ClearPoint Prism™ system, powered by CLS, have been demonstrated. We are also proud to present three new members that will strengthen the CLS team.Welcome the read the full newsetter in the attached pdf.